CONTEXT: We have reported lower hip bone mineral density (BMD) in adolescent boys with anorexia nervosa (AN) compared with controls. Although studies have described bone structure in girls with AN, these data are not available for boys. Hip structural analysis (HSA) using dual-energy x-ray absorptiometry is a validated technique to assess hip geometry and strength while avoiding radiation associated with quantitative computed tomography. OBJECTIVE: We hypothesized that boys with AN would have impaired hip structure/strength (assessed by HSA) compared with controls. DESIGN AND SETTING: We conducted a cross-sectional study at a clinical research center. SUBJECTS AND INTERVENTION: We used HSA techniques on hip dual-energy x-ray absorptiometry scans in 31 previously enrolled boys, 15 with AN and 16 normal-weight controls, 12 to 19 years old. RESULTS: AN boys had lower body mass index SD score (P < .0001), testosterone (P = .0005), and estradiol (P = .006) than controls. A larger proportion of AN boys had BMD Z-scores <-1 at the femoral neck (60% vs 12.5%, P = 0008). Using HSA, at the narrow neck and trochanter region, boys with AN had lower cross-sectional area (P = .03, 0.02) and cortical thickness (P = .02, 0.03). Buckling ratio at the trochanter region was higher in AN (P = .008). After controlling for age and height, subperiosteal width at the femoral shaft, cross-sectional moment of inertia (narrow neck and femoral shaft), and section modulus (all sites) were lower in AN. The strongest associations of HSA measures were observed with lean mass, testosterone, and estradiol. On multivariate analysis, lean mass remained associated with most HSA measures. CONCLUSIONS: Boys with AN have impaired hip geometric parameters, associated with lower lean mass.
CONTEXT: We have reported lower hip bone mineral density (BMD) in adolescent boys with anorexia nervosa (AN) compared with controls. Although studies have described bone structure in girls with AN, these data are not available for boys. Hip structural analysis (HSA) using dual-energy x-ray absorptiometry is a validated technique to assess hip geometry and strength while avoiding radiation associated with quantitative computed tomography. OBJECTIVE: We hypothesized that boys with AN would have impaired hip structure/strength (assessed by HSA) compared with controls. DESIGN AND SETTING: We conducted a cross-sectional study at a clinical research center. SUBJECTS AND INTERVENTION: We used HSA techniques on hip dual-energy x-ray absorptiometry scans in 31 previously enrolled boys, 15 with AN and 16 normal-weight controls, 12 to 19 years old. RESULTS: AN boys had lower body mass index SD score (P < .0001), testosterone (P = .0005), and estradiol (P = .006) than controls. A larger proportion of AN boys had BMD Z-scores <-1 at the femoral neck (60% vs 12.5%, P = 0008). Using HSA, at the narrow neck and trochanter region, boys with AN had lower cross-sectional area (P = .03, 0.02) and cortical thickness (P = .02, 0.03). Buckling ratio at the trochanter region was higher in AN (P = .008). After controlling for age and height, subperiosteal width at the femoral shaft, cross-sectional moment of inertia (narrow neck and femoral shaft), and section modulus (all sites) were lower in AN. The strongest associations of HSA measures were observed with lean mass, testosterone, and estradiol. On multivariate analysis, lean mass remained associated with most HSA measures. CONCLUSIONS:Boys with AN have impaired hip geometric parameters, associated with lower lean mass.
Authors: Stefan A Jackowski; Saija A Kontulainen; David M L Cooper; Joel L Lanovaz; Adam D G Baxter-Jones Journal: J Bone Miner Res Date: 2011-11 Impact factor: 6.741
Authors: Laura Audí; Deisi M Vargas; Miquel Gussinyé; Diego Yeste; Gertrudis Martí; Antonio Carrascosa Journal: Pediatr Res Date: 2002-04 Impact factor: 3.756
Authors: Emily M Stein; X Sherry Liu; Thomas L Nickolas; Adi Cohen; Valerie Thomas; Donald J McMahon; Chiyuan Zhang; Felicia Cosman; Jeri Nieves; Justin Greisberg; X Edward Guo; Elizabeth Shane Journal: J Clin Endocrinol Metab Date: 2011-04-20 Impact factor: 5.958
Authors: K Ramamurthi; O Ahmad; K Engelke; R H Taylor; K Zhu; S Gustafsson; R L Prince; K E Wilson Journal: Osteoporos Int Date: 2011-03-11 Impact factor: 4.507
Authors: A Z LaCroix; T J Beck; J A Cauley; C E Lewis; T Bassford; R Jackson; G Wu; Z Chen Journal: Osteoporos Int Date: 2009-09-15 Impact factor: 4.507
Authors: Peter Vestergaard; Charlotte Emborg; René K Støving; Claus Hagen; Leif Mosekilde; Kim Brixen Journal: Int J Eat Disord Date: 2002-11 Impact factor: 4.861
Authors: Jason M Nagata; Jennifer L Carlson; Neville H Golden; Stuart B Murray; Jin Long; Mary B Leonard; Rebecka Peebles Journal: Eat Weight Disord Date: 2018-06-08 Impact factor: 4.652
Authors: Melanie Schorr; Anne Drabkin; Micol S Rothman; Erinne Meenaghan; Gillian T Lashen; Margherita Mascolo; Ashlie Watters; Tara M Holmes; Kate Santoso; Elaine W Yu; Madhusmita Misra; Kamryn T Eddy; Anne Klibanski; Philip Mehler; Karen K Miller Journal: Clin Endocrinol (Oxf) Date: 2019-04-01 Impact factor: 3.478
Authors: Jason M Nagata; Neville H Golden; Mary B Leonard; Lawrence Copelovitch; Michelle R Denburg Journal: J Bone Miner Res Date: 2017-01-19 Impact factor: 6.741